UY29515A1 - Composiciones farmaceuticas que constan de peptidos derivados de la caseina y métodos del uso de los mismos - Google Patents
Composiciones farmaceuticas que constan de peptidos derivados de la caseina y métodos del uso de los mismosInfo
- Publication number
- UY29515A1 UY29515A1 UY29515A UY29515A UY29515A1 UY 29515 A1 UY29515 A1 UY 29515A1 UY 29515 A UY29515 A UY 29515A UY 29515 A UY29515 A UY 29515A UY 29515 A1 UY29515 A1 UY 29515A1
- Authority
- UY
- Uruguay
- Prior art keywords
- methods
- pharmaceutical compositions
- caseina
- compositions containing
- peptides derived
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000005018 casein Substances 0.000 abstract 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 abstract 2
- 235000021240 caseins Nutrition 0.000 abstract 2
- 235000013336 milk Nutrition 0.000 abstract 2
- 239000008267 milk Substances 0.000 abstract 2
- 210000004080 milk Anatomy 0.000 abstract 2
- 241000283690 Bos taurus Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 230000006651 lactation Effects 0.000 abstract 1
- 244000144972 livestock Species 0.000 abstract 1
- 239000000693 micelle Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000005192 partition Methods 0.000 abstract 1
- 239000008174 sterile solution Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Marine Sciences & Fisheries (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67629205P | 2005-05-02 | 2005-05-02 | |
| US68869705P | 2005-06-09 | 2005-06-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY29515A1 true UY29515A1 (es) | 2007-11-30 |
Family
ID=37308387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY29515A UY29515A1 (es) | 2005-05-02 | 2006-05-02 | Composiciones farmaceuticas que constan de peptidos derivados de la caseina y métodos del uso de los mismos |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US7968513B2 (enExample) |
| EP (1) | EP1890720B1 (enExample) |
| JP (1) | JP5247429B2 (enExample) |
| KR (2) | KR20130122979A (enExample) |
| CN (1) | CN106421749A (enExample) |
| AR (1) | AR059462A1 (enExample) |
| AU (1) | AU2006242842B2 (enExample) |
| BR (1) | BRPI0611301A2 (enExample) |
| CA (1) | CA2607155C (enExample) |
| CL (1) | CL2011000039A1 (enExample) |
| EA (1) | EA016039B1 (enExample) |
| ES (1) | ES2400511T3 (enExample) |
| IN (1) | IN2014DN10391A (enExample) |
| MX (1) | MX2007013866A (enExample) |
| NZ (1) | NZ563936A (enExample) |
| PL (1) | PL1890720T3 (enExample) |
| UY (1) | UY29515A1 (enExample) |
| WO (1) | WO2006117784A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2400511T3 (es) * | 2005-05-02 | 2013-04-10 | Mileutis Ltd. | Composiciones farmacéuticas que comprenden péptidos derivados de la caseina y métodos para el uso de las mismas |
| JP5507555B2 (ja) * | 2008-06-30 | 2014-05-28 | チョ−エー・ファーム・カンパニー・リミテッド | 豚のαＳ１カゼイン遺伝子、そのプロモーター、及びその用途 |
| US8133916B1 (en) | 2009-03-10 | 2012-03-13 | Amelgo, LLC | Control of milk production and mammary involution |
| US20110017323A1 (en) * | 2009-07-22 | 2011-01-27 | Ewa Herbst | Method and apparatus for inline testing |
| CA2797658C (en) * | 2010-04-21 | 2021-06-08 | Mileutis Ltd. | Casein peptide for use in the treatment of uterine infections |
| FR2971423B1 (fr) * | 2011-02-15 | 2014-01-10 | Ceva Sante Animale | Composition veterinaire antiprolactinique destinee aux ruminants |
| ES2759980T3 (es) | 2012-03-19 | 2020-05-12 | Mileutis Ltd | Péptidos para el manejo de la lactación |
| EP2810695A1 (en) * | 2013-06-06 | 2014-12-10 | Ceva Sante Animale | Compositions and Method for controlling infections in non-human mammals using acute phase proteins |
| AU2017358060B2 (en) * | 2016-11-09 | 2023-05-04 | Charles Sturt University | Livestock supplement and use thereof |
| CN110267550B (zh) * | 2016-12-13 | 2022-08-30 | 帝斯曼知识产权资产管理有限公司 | 多不饱和脂肪酸盐制剂(i) |
| CN108017709B (zh) * | 2017-12-12 | 2020-04-10 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽kepmigvnqela及其制备方法和应用 |
| MX2022010250A (es) * | 2020-02-19 | 2022-11-09 | Perfect Day Inc | Proteínas recombinantes hipoalergénicas de leche y composiciones que comprenden las mismas. |
| EP4619011A1 (en) * | 2022-11-17 | 2025-09-24 | Mileutis Ltd. | Compositions and methods for modulating mammary disorders and conditions |
| AU2024274533A1 (en) * | 2023-05-16 | 2025-12-04 | Mileutis Ltd. | Enhanced milk quality |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3764670A (en) * | 1970-10-28 | 1973-10-09 | Ministry Of Agriculture | Polypeptidic anti-biotic substances derived from casein |
| FR2474829B1 (fr) * | 1980-02-01 | 1983-09-09 | Agronomique Inst Nat Rech | Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications |
| US5405756A (en) * | 1982-03-30 | 1995-04-11 | Meiji Seika Kaisha, Ltd. | Transparent acid drink containing acid-soluble casein phosphopeptide |
| US5015628A (en) * | 1986-06-12 | 1991-05-14 | The University Of Melbourne | Anticariogenic phosphopeptides |
| ES2149771T3 (es) * | 1991-04-19 | 2000-11-16 | Univ Melbourne | Produccion de fosfopeptidos a partir de la caseina. |
| US5227154A (en) * | 1991-08-22 | 1993-07-13 | The University Of Melbourne | Phosphopeptides for the treatment of dental calculus |
| KR0140248B1 (ko) * | 1995-03-23 | 1998-06-15 | 한상기 | 신규한 카제인 포스포펩티드, 그것을 포함하는 카제인 및 그 제조방법 |
| AUPO566297A0 (en) * | 1997-03-13 | 1997-04-10 | University Of Melbourne, The | Calcium phosphopeptide complexes |
| AUPP494798A0 (en) * | 1998-07-29 | 1998-08-20 | Pacific Biolink Pty Limited | Protective protein formulation |
| AU775999B2 (en) | 1999-08-24 | 2004-08-19 | Meiji Seika Pharma Co., Ltd. | Growth promoting compositions for mammals and method of promoting the growth of mammals by using the same |
| US6391849B1 (en) * | 1999-11-19 | 2002-05-21 | Agricultural Research Organization, The Volcani Center | Method and pharmaceutical composition for disrupting lactation in a mammary gland and for treating and preventing mastitis |
| US7666996B2 (en) * | 2000-03-01 | 2010-02-23 | Peptera Pharmaceuticals Ltd | Casein derived peptides and uses thereof |
| IL134830A0 (en) * | 2000-03-01 | 2001-05-20 | Chay 13 Medical Res Group N V | Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them |
| CN1496368A (zh) * | 2001-03-09 | 2004-05-12 | 明治制果株式会社 | 免疫增强剂 |
| BRPI0507822A (pt) | 2004-03-01 | 2007-07-10 | Peptera Pharmaceuticals Ltd | método e composição farmacêutica para a prevenção ou o tratamento de uma doença ou uma condição autoimune ou infecciosa, método e composição farmacêutica para a prevenção ou o tratamento de uma doença ou uma condição do sangue, método e composição farmacêutica para modular a formação de células do sangue, método e composição farmacêutica para intensificar a mobilização periférico da célula tronco, método e composição farmacêutica para a prevenção ou o tratamento de uma doença ou uma condição metabólica, método e composição farmacêutica para a prevenção ou o tratamento das condições associadas com doses mieloablativas de quimioradioterapia suportadas pelo transplante autólogo de medula óssea ou de células tronco do sangue periférico (asct) ou pelo transplante alogenéico de medula óssea (bmt), método e composição farmacêutica para aumentar o efeito de um fator estimulante de células do sangue, método e composição farmacêutica para intensificar a colonização de células tronco do sangue doadas em um receptor mieloablatado, método e composição farmacêutica para a prevenção ou o tratamento de uma doença ou uma condição bacteriana, composição farmacêutica para o tratamento ou a prevenção de uma indicação selecionada do grupo que consiste em doença ou condição autoimune, doença viral, infecção viral, doença hematológica, deficiências hematológicas, trombocitopenia, pancitopenia, granulopenia, hiperlipidemia, hipercolesterolemia, glucosuria, hiperglicemia, diabetes, aids, hiv-1, distúrbios de células t auxiliares, deficiências de células dendrìticas, deficiências de macrofagos, distúrbios de células tronco hematopoiéticas incluindo distúrbios com plaquetas, linfócitos, células do plasma e neutrófilos, condições pré-leucêmicas, condições leucêmicas, distúrbios do sistema imunológico resultantes da terapia de quimioterapia ou de radiação, distúrbios do sistema imunológico humano resultantes do tratamento das doenças de deficiência imunológica e infecções bacterianas, composição farmacêutica para o tratamento ou a prevenção de um indicação selecionada do grupo que consiste em doença hematológica, deficiências hematológicas, trombocitopenia, pancitopenia, granulopenia, deficiências de células dendrìticas, deficiências de macrofagos, distúrbios de células tronco hematopoiéticas incluindo distúrbios com plaquetas, linfócitos, células do plasma e neutrófilos, condições pré-leucêmicas, condições leucêmicas, sìndrome mielodisplástiacas, malignidades não mielóides, anemia plástica e insuficiência da medula óssea, peptìdeo purificado, peptìdeo quimérico purificado, peptìdeo quimérico, composição farmacêutica, composição farmacêutica para a prevenção ou o tratamento de uma condição associada com um agente infeccioso de sars, método de processamento a baixa temperatura de hidrolisato proteolìtico de caseìna e hidrolisato de proteìna de caseìna |
| ES2400511T3 (es) * | 2005-05-02 | 2013-04-10 | Mileutis Ltd. | Composiciones farmacéuticas que comprenden péptidos derivados de la caseina y métodos para el uso de las mismas |
-
2006
- 2006-05-02 ES ES06728320T patent/ES2400511T3/es active Active
- 2006-05-02 JP JP2008509574A patent/JP5247429B2/ja active Active
- 2006-05-02 BR BRPI0611301-0A patent/BRPI0611301A2/pt not_active Application Discontinuation
- 2006-05-02 NZ NZ563936A patent/NZ563936A/en unknown
- 2006-05-02 PL PL06728320T patent/PL1890720T3/pl unknown
- 2006-05-02 WO PCT/IL2006/000524 patent/WO2006117784A2/en not_active Ceased
- 2006-05-02 CA CA2607155A patent/CA2607155C/en active Active
- 2006-05-02 AU AU2006242842A patent/AU2006242842B2/en active Active
- 2006-05-02 MX MX2007013866A patent/MX2007013866A/es active IP Right Grant
- 2006-05-02 IN IN10391DEN2014 patent/IN2014DN10391A/en unknown
- 2006-05-02 EA EA200702401A patent/EA016039B1/ru not_active IP Right Cessation
- 2006-05-02 CN CN201610544021.9A patent/CN106421749A/zh active Pending
- 2006-05-02 UY UY29515A patent/UY29515A1/es not_active Application Discontinuation
- 2006-05-02 KR KR1020137025206A patent/KR20130122979A/ko not_active Ceased
- 2006-05-02 US US11/913,239 patent/US7968513B2/en active Active
- 2006-05-02 EP EP06728320A patent/EP1890720B1/en active Active
- 2006-05-15 AR ARP060101766A patent/AR059462A1/es not_active Application Discontinuation
-
2007
- 2007-12-03 KR KR1020077028185A patent/KR101340676B1/ko active Active
-
2011
- 2011-01-07 CL CL2011000039A patent/CL2011000039A1/es unknown
- 2011-05-13 US US13/107,331 patent/US8338363B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CL2011000039A1 (es) | 2011-06-10 |
| KR101340676B1 (ko) | 2013-12-18 |
| EP1890720B1 (en) | 2013-01-09 |
| AU2006242842B2 (en) | 2011-12-08 |
| KR20080012933A (ko) | 2008-02-12 |
| CA2607155C (en) | 2016-09-13 |
| PL1890720T3 (pl) | 2013-06-28 |
| US20110212886A1 (en) | 2011-09-01 |
| WO2006117784A2 (en) | 2006-11-09 |
| NZ563936A (en) | 2010-03-26 |
| JP5247429B2 (ja) | 2013-07-24 |
| IN2014DN10391A (enExample) | 2015-08-14 |
| AR059462A1 (es) | 2008-04-09 |
| EP1890720A2 (en) | 2008-02-27 |
| AU2006242842A1 (en) | 2006-11-09 |
| EP1890720A4 (en) | 2010-05-26 |
| ES2400511T3 (es) | 2013-04-10 |
| KR20130122979A (ko) | 2013-11-11 |
| US7968513B2 (en) | 2011-06-28 |
| US8338363B2 (en) | 2012-12-25 |
| CA2607155A1 (en) | 2006-11-09 |
| MX2007013866A (es) | 2008-04-07 |
| EA016039B1 (ru) | 2012-01-30 |
| WO2006117784A3 (en) | 2009-05-22 |
| JP2008540399A (ja) | 2008-11-20 |
| EA200702401A1 (ru) | 2008-08-29 |
| US20090069218A1 (en) | 2009-03-12 |
| BRPI0611301A2 (pt) | 2010-08-31 |
| CN106421749A (zh) | 2017-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY29515A1 (es) | Composiciones farmaceuticas que constan de peptidos derivados de la caseina y métodos del uso de los mismos | |
| CR20110441A (es) | Preparaciones para la sincronicación de ciclo estral y protocolos sin cidr efectivos. | |
| CO6592076A2 (es) | Composiciones de higiene oral | |
| ES2189198T3 (es) | Equipo automatico para lavar, desinfectar, secar y estimular las mamas de vacas lecheras. | |
| DK2269445T3 (da) | Indretning til hold af malkedyr | |
| MX2015005607A (es) | Composicion en polvo para desinfeccion de las ubres de los animales lecheros. | |
| CO2020002967A2 (es) | Desinfectante novedoso para criaderos | |
| AR042810A1 (es) | Tejido higienico apropiado para la limpieza y transferencia de bacterias productoras de acido lactico a la piel o al area urogenital. | |
| RU2013155085A (ru) | Лечение мастита | |
| MX2019002386A (es) | Uso de oligosacaridos de leche humana en el engorde de terneros. | |
| MX2016017366A (es) | Productos sustituidos de leche que contienen haluros y fuentes de peroxido de hidrogeno y metodos para alimentar los mismos. | |
| MX2017006801A (es) | Eficiencia de produccion de leche mejorada en vacas lecheras. | |
| CR8384A (es) | Metodos y composiciones para la inhibicion de selectina | |
| MX2014012421A (es) | Sistema y metodo para utilizar robots junto con una plataforma de ordeña giratoria. | |
| RU2010143584A (ru) | Вакцина для защиты от haemophilus parasuis серотипа 4 у поросят | |
| CL2012002768A1 (es) | Solucion antiseptica para prevencion de mastitis subclinica en vacas lecheras que comprende una mezcla de propoleo y solucion de miel de abejas en proporciones desde 1:5 a 5:1, uso de la solucion antiseptica porque sirve para la profilaxis, prevencion y control de mastitis subclinica de vacas lecheras. | |
| Smith et al. | Development and Evaluation of Teat Coverage Persistency for New Prototype Dry Period Persistent Barrier Teat Dips | |
| Álvarez et al. | Herd and milking as mastitis risk factors in Brazil-preliminary results. | |
| RU2008124738A (ru) | Кормовая добавка | |
| Delpech et al. | New bacteriocin of E. Faecalis CECT7121: synergy studies against multidrug-resistant enterococci isolated from bovine mastitis | |
| Sousa et al. | Morphometry of the papillary ostium of the udder of dairy cows. | |
| RU2013108490A (ru) | Способ определения годовой мясной продуктивности коров мясной породы шароле | |
| Améndola-Massiotti et al. | The behaviour of dairy cows with artificial shade in a temperate region of Mexico | |
| Pérez et al. | Carcass characteristics in hair sheep. | |
| CO6592017A2 (es) | Encapsulación de ingredientes en una matriz de lactosa para formar encapsulados activos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20161208 |